MoneyWorks4Me

Amrutanjan Health Care informs about updates

18 Oct 2025 Evaluate
Pursuant to the Regulation 30 read with Clause 20 of Para A of Part A of Schedule Ill of SEBI Listing Regulations, Amrutanjan Health Care has submitted the details of the order received by the Company under the CGST/IGST Act, 2017. The Company does not agree with the Order and will take appropriate action(s) for rectification/reversal of the same. As required under the SEBI Circular no. SEBI/HO/CFD/CFD-PoD-I/P/CIR/2023/ 123 dated July 13, 2023 the details are enclosed. 

The above information is a part of company’s filings submitted to BSE.  
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..